We believe that nobody in the world should die from a treatable infection. Our ambition is to empower clinician decision-making and tackle the common challenges that have led to sepsis becoming the number one cause of death worldwide. We are bringing change into the world through the research and development of a next-generation diagnostic device.
Together, we can win this fight.
Founded in 2019, GenomeKey brought together scientists, engineers, and clinicians to build a next generation diagnostic device that would transform how we treat sepsis.
We realised early on that the twin revolutions in DNA sequencing and machine learning meant it was now possible to identify and profile bacteria directly from patient blood, accurately and cheaply.
Having raised seed funding, we set out to build this vision. We hired some of the brightest minds in molecular biology, machine learning, and microbiology, and stocked a state of the art laboratory.
We have proven our technology and now we are engaging with global healthcare to demonstrate the clinical benefit of our system in the real world.
We are always on the lookout for more partners, more opportunities for impact, and new ways to improve. If you are passionate about what we’re doing and want to get involved, please get in touch.
We are passionate innovators.
Our expert team consists of a variety of people and skills with one thing in common – we’re all dedicated to building a safer and healthier future.